Robert Whitmore, MD
Neurological Surgery · Burlington, MANPI 1669521068
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,837 of the $25,086 with a category attached, or 87.0%. Depuy Synthes Products, Inc. accounts for 67.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $15,348 and has fallen 73.2% since, to $4,121 in 2025.
Across 55 payments — averaging $456.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$17K
- Intrinsic Therapeutics$5K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$909
- Medtronic$102
Across 38 payments — averaging $6385.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$181K
- Premia Spine, Ltd.$52K
- Intrinsic Therapeutics$10K
What the payments were for
- Consulting fees$21,83787%
- Travel & lodging$1,7427%
- Food & beverage$1,5076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 28 | $16,992 |
| Intrinsic Therapeutics | 7 | $5,100 |
| Medical Device Business Services, Inc. | 7 | $1,983 |
| Johnson & Johnson | 11 | $909 |
| Medtronic | 2 | $102 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$10,200
- Spine & Trauma 3D Navigation$5,922
- CONDUIT$254
- SYMPHONY$141
- Teligen$132
- Velys$126
- FIBERGRAFT BG Morsels$115
- EXPEDIUM$101
How this compares
$25,086 in reported general payments places this provider in the 80th percentile of 183 neurological surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 107 | $1,011 |
| Gabapentin | 81 | $767 |
| Tizanidine Hcl | 18 | $125 |
| Methylprednisolone | 17 | $96 |
| Tramadol Hcl | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Burlington
- Jeffrey ArleBurlington$284K
- Erica BissonBurlington$240K
- Jonathan PaceBurlington$25K
- Andrew YewBurlington$13K
- Simcha WellerBoston$905K
- Paul HouleHyannis$774K
- Aman PatelBoston$734K
- Alireza AtriBoston$503K
- Frederik PenningsWorcester$471K
- Myron RolleBoston$290K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.